Correction to: a facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanopartic
- PDF / 334,586 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 97 Downloads / 176 Views
CORRECTION
Correction to: a facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers Poonam Parashar 1 & Chandra Bhushan Tripathi 1 & Malti Arya 1 & Jovita Kanoujia 1 & Mahendra Singh 1 & Abhishek Yadav 1 & Shubhini A. Saraf 1
# Controlled Release Society 2020
Correction to: Drug Delivery and Translational Research (2019) 9:37–52 https://doi.org/10.1007/s13346-018-0575-8 In the original article the blots for BAX were inadvertently flipped in Fig. 11a. The inadvertent error in the case of BAX does not change any of the results. The corrected version is given below.
The online version of the original article can be found at https://doi.org/ 10.1007/s13346-018-0575-8 * Shubhini A. Saraf [email protected] 1
Department of Pharmaceutical Sciences, Babasaheb Bhimrao, Ambedkar University (A Central University), Vidya Vihar, Raebareli, Road, Lucknow, U.P 226025, India
Drug Deliv. and Transl. Res. Fig. 11 a Immunoblot representing the regulation of mitochondria associated apoptosis modulating proteins isolated from lung tumor tissue of individual groups
Publishe's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Data Loading...
